The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Apolipoprotein E Highly Correlates with AβPP- and Tau-Related Markers in Human Cerebrospinal Fluid
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
PLTP transfers phospholipids to HDL in plasma.
“PLTP, which is reported to transfer phospholipids to HDL in plasma, has reduced activity in human AD patient CSF [101, 102].”
From ApoE lipoproteins in the central nervous system under homeostasis and role in Alzheimer’s disease and related disorders (2026) · cites this paper as [102]
The Introduction says PLTP transfers phospholipids between lipoproteins and cells. The Methods describe CSF PLTP transferring phospholipids to plasma-derived HDL in an assay, but do not establish that this transfer occurs in plasma. (LLM, conf=0.83)
Experimental — accuracy not yet measuredPLTP has reduced activity in human Alzheimer's disease patient CSF.
“PLTP, which is reported to transfer phospholipids to HDL in plasma, has reduced activity in human AD patient CSF [101, 102].”
From ApoE lipoproteins in the central nervous system under homeostasis and role in Alzheimer’s disease and related disorders (2026) · cites this paper as [102]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition
Bales, K. R., Verina, T., Dodel, R. C., Du, Y., Altstiel, L., Bender, M., Hyslop, P., Johnstone, E. M., Little, S. P., Cummins, D. J., et al. (1997) · Nature Genetics · doi:10.1038/ng1197-263 · Cited by 830
Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins
Pitas, R. E., Boyles, J. K., Lee, S. H., Foss, D., & Mahley, R. W. (1987) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(87)90295-5 · Cited by 693
Causes of oxidative stress in Alzheimer disease
Zhu, X., Su, B., Wang, X., Smith, M. A., & Perry, G. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7218-4 · Cited by 336
Sadowski, M., Pankiewicz, J., Scholtzova, H., Ripellino, J. A., Li, Y., Schmidt, S. D., Mathews, P. M., Fryer, J. D., Holtzman, D. M., Sigurdsson, E. M., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63355-x · Cited by 154
Hirsch-Reinshagen, V., & Wellington, C. L. (2007) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32813aeabf · Cited by 61
Apolipoprotein E decreases tau kinases and phospho-tau levels in primary neurons.
Hoe, H.-S., Freeman, J., & Rebeck, G. W. (2006) · Molecular Neurodegeneration · doi:10.1186/1750-1326-1-18 · Cited by 45
Flagged first, then by citations
Research works printed but not linked: 44
- Albers JJ Wolfbauer G Cheung MC Day JR Ching AF Lok S Tu AY Functional expression of human and mouse plasma phospholipid transfer protein: effect of recombinant and plasma PLTP on HDL subspecies Biochim Biophys Acta 1995 1258 27 34 7654777
- Bales KR Verina T Cummins DJ Du Y Dode JC Saura J Fishman CE DeLong CA Piccardo P Petegnief V Ghetti B Paul SM Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease Proc Natl Acad Sci USA 1999 96 15233 15238 10611368 PMC24803
- Berlau DJ Kahle-Wrobleski K Head E Goodus M Kim R Kawas C Dissociation of neuropathologic findings and cognition: case report of an apolipoprotein E epsilon2/epsilon2 genotype Arch Neurol 2007 64 1193 1196 17698712 PMC3378248
- Berr C Hauw JJ Delaere P Duyckaerts C Amouyel P Apolipoprotein E allele epsilon 4 is linked to increased deposition of the amyloid beta-peptide (A-beta) in cases with or without Alzheimer's disease Neurosci Lett 1994 178 221 224 7824200
- Champagne D Pearson D Dea D Rochford J Poirier J The cholesterol-lowering drug Probucol increases apolipoprotein E production in the hippocampus of aged rats: implications for Alzheimer's disease Neuroscience 2003 121 99 110 12946703
- Cheung MC Wolfbauer G Albers JJ Plasma phospholipid mass transfer rate: relationship to plasma phospholipid and cholesteryl ester transfer activities and lipid parameters Biochim Biophys Acta 1996 1303 103 110 8856039
- Corder EH Saunders AM Strittmatter WJ Schmechel DE Gaskell PC Small GW Roses AD Haines JL Pericak-Vance MA Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families Science 1993 261 921 923 8346443
- Desrumaux C Risold PY Schroeder H Deckert V Masson D Athias A Laplanche H Guern NL Blache D Jiang XC Tall A Desor D Lagrost L Phospholipid transfer protein (PLTP) deficiency reduces brain vitamin E content and increases anxiety in mice FASEB J 2005 19 296 297 15576481
- Emi M Wu LL Robertson MA Myers RL Hegele RA Williams RR White R Lalouel JM Genotyping and sequence analysis of apolipoprotein E isoforms Genomics 1988 3 373 379 3243553
- Evans KC Berger EP Cho CG Weisgraber KH Lansbury PT Jr Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease Proc Natl Acad Aci USA 1995 92 763 767 PMC42700 7846048
- Galasko D Chang L Motter R Clark CM Kaye J Knopman D Thomas R Kholodenko D Schenk D Liebergurg I Miller B Green R Basherad R Kertiles L Boss MA Seubert P High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype Arch Neurol 1998 55 937 945 9678311
- Glodzik-Sobanska L Pirraglia E Brys M de Santi S Mosconi L Rich KE Switalski R Louis LS Sadowski MJ Martiniuk F Mehta P Pratico D Zinkowski RP Blennow K de Leon MJ The effects of normal aging and apoE genotype on the levels of CSF biomarkers for Alzheimer's disease Neurobiol Aging 2008 in press PMC2774788 17920160
- Ignatius MJ Shooter EM Pitas RE Mahley RW Lipoprotein uptake by neuronal growth cones in vitro Science 1987 236 959 962 3576212
- Iqbal K Grundke-Iqbal I Discoveries of tau, abnormally hyperphosphorylated tau and others of neurofibrillary degeneration: a personal historical perspective J Alzheimers Dis 2006 9 219 242 16914861
- Irizarry MC Deng A Lleo A Berzovska O von Arnim CA Martin-Rehrmann M Manelli A LaDu MJ Hyman BT Rebeck GW Apolipoprotein E modulates gamma-secretase cleavage of the amyloid precursor protein J Neurochem 2004 90 1132 1143 15312168
- Johnson-Wood K Lee M Motter R Hu K Gordon G Barbour R Khan K Gordon M Tan H Games D Lieberburg I Schenk D Seubert P McConlouge L Amyloid precursor protein processing and Abeta42 deposition in a transgenic mouse model of Alzheimer's disease Proc Nat Acad Sci USA 1997 94 1550 1555 9037091 PMC19829
- Kostner GM Oettl K Jauiainen M Ehnholm C Esterbauer H Dieplinger H Human plasma phospholipid transfer protein accelerates exchange/transfer of alpha-tocopherol between lipoproteins and cells Biochem J 1995 305 659 667 7832785 PMC1136412
- Lauderback CM Hackett JM Keller JN Varadarajan S Szweda L Kindy M Markesbery WR Butterfield DA Vulnerability of synaptosomes from apoE knock-out mice to structural and oxidative modifications induced by A beta(1-40): implications for Alzheimer's disease Biochemistry 2001 40 2548 2554 11327877
- Lee EB Zhang B Liu K Greenbaum E Doms RW Trojanowski JQ Lee VM-Y BACE overexpression alters the subcellular processing of APP and inhibits Abeta deposition in vivo J Cell Biol 2005 168 291 302 15642747 PMC2171598
- Lippa CF Smith TW Saunders AM Hulette C Pulaski-Salo D Roses AD Apolipoprotein E-epsilon 2 and Alzheimer's disease: genotype influences pathologic phenotype Neurology 1997 48 515 519 9040748
- Mahley RW Apolipoprotein E: cholesterol transport protein with expanding role in cell biology Science 1988 240 622 630 3283935
- Masliah E Samuel W Veinbergs I Mallory M Mante M Saitoh T T Neurodegeneration and cognitive impairment in apoE-deficient mice is ameliorated by infusion of recombinant apoE Brain Res 1997 751 307 314 9099820
- Mauch DH Nagler K Schumacher S Goritz C Muller EC Otto A Pfrieger FW CNS synaptogenesis promoted by glia-derived cholesterol Science 2001 294 1354 1357 11701931
- Mayeux R Stern Y Ottman R Tatemichi TK Tang MX Maestre G Ngai C Tycko B Ginsberg H The apolipoprotein epsilon 4 allele in patients with Alzheimer's disease Ann Neurol 1993 34 752 754 8239575
- Nishida HI Nishida T Phospholipid transfer protein mediates transfer of not only phosphatidylcholine but also cholesterol from phosphatidylcholine-cholesterol vesicles to high density lipoproteins J Biol Chem 1997 272 6959 6964 9054384
- Ohkubo N Lee YD Morishima A Terashima T Kikkawa S Tohyama M Sakanaka M Tanaka J Maeda N Vitek MP Mitsuda N Apolipoprotein E and Reelin ligands modulate tau phosphorylation through an apolipoprotein E receptor/disabled-1/glycogen synthase kinase-3beta cascade FASEB J 2003 17 295 297 12490540
- Olesen OF Dago L High density lipoprotein inhibits assembly of amyloid beta-peptdies into fibrils Biochem Biophys Res Commun 2000 270 62 66 10733905
- Oram JF Wolfbauer G Vaughan AM Tang C Albers JJ Phospholipid transfer protein interacts with and stabilizes ABCA1 and enhances cholesterol efflux from cells J Biol Chem 2003 278 52379 52385 14559902
- Peskind ER Riekse R Quinn JF Kaye J Clark CM Farlow MR Decarli C Chabai C Vavrek D Raskind MA Galasko D Safety and acceptability of the research lumbar puncture Alzheimer Dis Assoc Disord 2005 19 220 225 16327349
- Pitas RE Boyles JK Lee SH Hui D Weisgraber KH KH Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B, E(LDL) receptors in the brain J Biol Chem 1987 262 1 14352 14360 3115992
- Rao R Albers JJ Wolfbauer G Pownall HJ Molecular and macromolecular specificity of human plasma phospholipid transfer protein Biochemistry 1997 36 3645 3653 9132017
- Reddy PH Mani G Park BS Jacques J Murdoch G Whetsell W Jr Kaye J Manczak M Differential loss of synaptic proteins in Alzheimer's disease: implications for synaptic dysfunction J Alzheimers Dis 2005 7 103 117 15851848
- Sunderland T Mirza N Putnam KT Linker G Bhupali D Durham R Soares H Kimmel L Friedman D Bergeson J Csako G Levy JA Bartko JJ Cohen RM Cerebrospinal fluid β-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE ε4 allele J Biopsych 2004 56 670 676 15522251
- Suzuki N Cheung TT Cai XD Odaka A Otvos L Jr Eckman C Golde TE Younkin SG An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants Science 1994 264 1336 1340 8191290
- Swertfeger DK Hui DY Apolipoprotein E: a cholesterol transport protein with lipid transport-independent cell signalling properties Front Biosci 2001 6 D526 D535 11229881
- Tannenberg RK Scott HL Tannenberg AE Dodd PR Selective loss of synaptic proteins in Alzheimer's disease: evidence for an increased severity with APOE varepsilon4 Neurochem Int 2006 49 631 639 16814428
- Tu AY Nishida HI Nishida T High density lipoprotein conversion mediated by human plasma phospholipid transfer protein J Biol Chem 1993 268 23098 230105 8226827
- Vaya J Schipper HM Oxysterols, cholesterol home-ostasis, and Alzheimer's disease J Neurochem 2007 102 1727 1737 17573819
- Vuletic S Jin LW Marcovina SM Peskind ER Moller T Albers JJ Widespread distribution of PLTP in human CNS: evidence for PLTP synthesis by glia and neurons, and increased levels in Alzheimer's disease J Lipid Res 2003 44 1113 1123 12671035
- Vuletic S Peskind ER Marcovina SM Quinn JF Cheung MC Kennedy H Kaye JA Jin LW Albers JJ Reduced CSF PLTP activity in Alzheimer's disease and other neurological diseases; PLTP induces apoE secretion in primary human astrocytes in vitro J Neurosci Res 2005 80 406 413 15795933
- Wang H Durham L Dawson H Song P Warner DS Sullivan PM Vitek MP Laskowitz DT An apolipoprotein E-based therapeutic improves outcome and reduces Alzheimer's disease pathology following closed head injury: evidence of pharmacogenomic interaction Neuroscience 2007 144 1324 1333 17187933
- Windler EE Kovanen PT Chao YS Brown MS Havel RJ Goldstein JL The estradiol-stimulated lipoprotein receptor of rat liver. A binding site that membrane mediates the uptake of rat lipoproteins containing apolipoproteins B and E J Biol Chem 1980 255 10464 10471 6253476
- Wisniewski T Castano EM Golabek A Vogel T Frangione B Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro Am J Pathol 1994 145 1030 1035 7977635 PMC1887417
- Wolfbauer G Albers JJ Oram JF Phospholipid transfer protein enhances removal of cellular cholesterol and phospholipids by high-density lipoprotein apolipoproteins Biochim Biophys Acta 1999 1439 65 76 10395966
Cited by
Sorted by citations
Strickland, M. R., & Holtzman, D. M. (2026) · Molecular Neurodegeneration · doi:10.1186/s13024-026-00970-0
Metadata
- Authors
- Vuletic, S., Li, G., Peskind, E. R., Kennedy, H., Marcovina, S. M., Leverenz, J. B., Petrie, E. C., Lee, V. M.-Y., Galasko, D., Schellenberg, G. D., & Albers, J. J.
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2008-10-24
- Volume
- 15
- Issue
- 3
- Pages
- 409-417
- ISSN
- 1875-8908
- 1387-2877
- PMC
- PMC2667787
- Cited by
- 12
- References
- 6
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
